Synthesis and Biological Evaluation of Novel 2‐(Piperidin‐4‐yl)‐1,2,3,4‐tetrahydroisoquinoline and 2‐(Piperidin‐4‐yl)decahydroisoquinoline Antimycotics
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.70128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Marie-Christin Hain und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Center of Drug Research, Ludwig-Maximilians University Munich, Munich, Germany. Hauptthemen laut MEDLINE: Antifungal Agents, Tetrahydroisoquinolines, Isoquinolines, Candida. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this study..
Abstract (Originalsprache)
Piperidine antimycotics like fenpropidin are well established in agrochemistry. On the other hand, numerous isoquinoline derivatives show remarkable antimycotic effects. Here we present a series of 13 hybrid molecules of both lead structures, which were prepared using reductive amination as key reaction step. Pre‐screening against Yarrowia lipolytica resulted in a batch of promising candidates whose antifungal efficacy was further evaluated against clinically relevant species. In these assays, complete growth inhibition was seen for five or six compounds against C. albicans or C. krusei , respectively, and in two against C. glabrata , whereas no antifungal activity was observed against mold isolates, with the exception of 6i , which led to complete growth inhibition of aspergilli, and two compounds ( 6k and 6 l ) that were able to inhibit Rhizopus arrhizus .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Center of Drug Research, Ludwig-Maximilians University Munich, Munich, Germany.
- Institute of Hygiene and Medical Microbiology, Department of Hygiene, Microbiology and Virology, Medical University Innsbruck, Innsbruck, Austria.
ORCID-Profile: Franz Bracher, Ulrike Binder, Jürgen Krauß
Förderung
- The authors received no specific funding for this study.
Zitieren
APA
Hain, M. C., Klimt, M., Bracher, F., Binder, U., & Krauß, J. (2025). Synthesis and Biological Evaluation of Novel 2‐(Piperidin‐4‐yl)‐1,2,3,4‐tetrahydroisoquinoline and 2‐(Piperidin‐4‐yl)decahydroisoquinoline Antimycotics. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70128
Vancouver
Hain MC, Klimt M, Bracher F, Binder U, Krauß J. Synthesis and Biological Evaluation of Novel 2‐(Piperidin‐4‐yl)‐1,2,3,4‐tetrahydroisoquinoline and 2‐(Piperidin‐4‐yl)decahydroisoquinoline Antimycotics. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70128
BibTeX
@article{Hain2025,
author = {Hain, Marie-Christin and Klimt, Monika and Bracher, Franz and Binder, Ulrike and Krauß, Jürgen},
title = {Synthesis and Biological Evaluation of Novel 2‐(Piperidin‐4‐yl)‐1,2,3,4‐tetrahydroisoquinoline and 2‐(Piperidin‐4‐yl)decahydroisoquinoline Antimycotics},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.70128}
}
EUVIMED